CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-26 | REICIN ALISE Chief Executive Officer | Option exercise | +10,000 | $2.38 | $24K | 319,078 |
| 2026-10-26 | REICIN ALISE Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 12,957 | ||
| 2026-09-25 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −1,545 | $23.67 | $37K | 309,078 |
| 2026-09-03 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +69,250 | 69,250 | ||
| 2026-06-20 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −924 | $30.34 | $28K | 310,623 |
| 2026-03-04 | REICIN ALISE Chief Executive Officer | Grant or award | +76,500 | 311,547 | ||
| 2026-03-04 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +69,250 | 69,250 | ||
| 2026-02-11 | REICIN ALISE Chief Executive Officer | Purchase | +2,500 | $21.10 | $53K | 127,030 |
| 2026-02-11 | REICIN ALISE Chief Executive Officer | Purchase | +2,500 | $21.10 | $53K | 237,547 |
| 2026-02-04 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −4,104 | $23.22 | $95K | 235,047 |
| 2025-12-31 | REICIN ALISE Chief Executive Officer | Option exercise | +10,966 | $2.38 | $26K | 239,151 |
| 2025-12-31 | REICIN ALISE Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,966 | 22,957 | ||
| 2025-09-25 | REICIN ALISE Chief Executive Officer | Grant or award | +14,700 | 228,185 | ||
| 2025-09-25 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +26,710 | 26,710 | ||
| 2025-06-20 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −859 | $19.81 | $17K | 213,485 |
| 2025-02-04 | REICIN ALISE Chief Executive Officer | Grant or award | +36,047 | 214,344 | ||
| 2025-02-04 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +101,953 | 101,953 | ||
| 2024-12-04 | REICIN ALISE Chief Executive Officer | Grant or award | +11,717 | 178,297 | ||
| 2024-12-04 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2024-06-20 | REICIN ALISE Chief Executive Officer | Grant or award | +166,580 | 166,580 |
Page 1 of 2 · 24 trades